Trevi Therapeutics TRVI
NASDAQ TRVI
$12.61 -0.33 (-2.55%)
At close: Oct 23, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Cash & Current Investments (2018 - 2026)

Updated

Trevi Therapeutics' Cash & Current Investments came in at $318.87 million for Q2 2026, up 56.4% from $203.89 million a year earlier and up 85.6% from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Trevi Therapeutics' Cash & Current Investments was $188.26 million, up 74.9% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 33.1% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $107.62 million in FY2024 (+29.7%), $82.97 million in FY2023 (-31.2%), $120.51 million in FY2022 (+227.2%) and $36.83 million in FY2021 (-18.2%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q1 2018.
  • Year-over-year, Cash & Current Investments has increased for seven consecutive quarters, with growth averaging 79.2% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2022 (growth of 328.4%), and the weakest in Q3 2021 (a decline of 45.0%).
  • Business Quant data shows TRVI's Cash & Current Investments at $171.78 million (Q1 2026), $188.26 million (Q4 2025) and $194.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Trevi Therapeutics 1.98 Bn 1.10 Bn - 318.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 318.87 Mn
Mar 31, 2026 171.78 Mn
Dec 31, 2025 188.26 Mn
Sep 30, 2025 194.93 Mn
Jun 30, 2025 203.89 Mn
Mar 31, 2025 103.26 Mn
Dec 31, 2024 107.62 Mn
Sep 30, 2024 65.49 Mn
Jun 30, 2024 69.50 Mn
Mar 31, 2024 72.82 Mn
Dec 31, 2023 82.97 Mn
Sep 30, 2023 88.87 Mn
Jun 30, 2023 94.15 Mn
Mar 31, 2023 111.26 Mn
Dec 31, 2022 120.51 Mn
Sep 30, 2022 125.60 Mn
Jun 30, 2022 77.86 Mn
Mar 31, 2022 29.11 Mn
Dec 31, 2021 36.83 Mn
Sep 30, 2021 29.32 Mn
API Access

Trevi Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TRVI&period=max&api_key=YOUR_API_KEY